These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Lithium in tardive dyskinesia. Simpson GM; Branchey MH; Lee JH; Voitashevsky A; Zoubok B Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):76-80. PubMed ID: 790411 [TBL] [Abstract][Full Text] [Related]
28. Double blind controlled trial of deanol in tardive dyskinesia. George J; Pridmore S; Aldous D Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835 [TBL] [Abstract][Full Text] [Related]
29. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia]. Lambert PA; Wolff P; de Maximy B; Ghenim A Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832 [No Abstract] [Full Text] [Related]
30. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184 [TBL] [Abstract][Full Text] [Related]
31. A review of clinical trials of lithium in neurology. Yung CY Pharmacol Biochem Behav; 1984; 21 Suppl 1():57-64. PubMed ID: 6240662 [TBL] [Abstract][Full Text] [Related]
32. Tardive dyskinesia in Tourette syndrome. Golden GS Pediatr Neurol; 1985; 1(3):192-4. PubMed ID: 3880404 [TBL] [Abstract][Full Text] [Related]
33. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia. Morselli PL; Fournier V; Bossi L; Musch B Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656 [TBL] [Abstract][Full Text] [Related]
34. Baclofen in tardive dyskinesia patients maintained on neuroleptics. Stewart RM; Rollins J; Beckham B; Roffman M Clin Neuropharmacol; 1982 Dec; 5(4):365-73. PubMed ID: 6130838 [TBL] [Abstract][Full Text] [Related]
35. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials. Tammenmaa IA; Sailas E; McGrath JJ; Soares-Weiser K; Wahlbeck K Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1099-107. PubMed ID: 15610922 [TBL] [Abstract][Full Text] [Related]
38. [Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia]. Kozian R; Friederich M Psychiatr Prax; 2007 Jul; 34(5):253-4. PubMed ID: 17597439 [TBL] [Abstract][Full Text] [Related]
39. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Correll CU; Leucht S; Kane JM Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963 [TBL] [Abstract][Full Text] [Related]
40. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. Miller DD; Eudicone JM; Pikalov A; Kim E J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]